Improve VTE Care and Prevention
Venous thromboembolism (VTE), encompassing pulmonary embolism (PE) and deep venous thrombosis (DVT), is a major cause of morbidity and mortality.1 Hospitalists often care for patients with VTE and can lead their institutions in safe approaches to treatment by developing strategies to operationalize cost-effective programs that will improve patient outcomes and reduce financial burden.
Recent increases in the number of available anticoagulants, advances in diagnostic algorithms, risk stratification and prognostication tools have rapidly transformed the care of VTE patients over the past several years. New advances include easier and safer treatment options, and cost-effective diagnostic strategies and tools that help triage PE patients with “large clots” toward thrombolysis and patients with “small clots” toward outpatient management without the need for prolonged hospitalization. Additionally, SHM and its partners have developed effective strategies for the prevention of long-term consequences of VTE, including recurrence and post-thrombotic syndrome.
This guide provides a "quick-read" resource on VTE treatment.
The 10th edition update includes comprehensive guidelines on antithrombotic therapy for VTE disease and expert guidance documents, such as those published by the acforum.org. It addresses key topics, including outpatient treatment of DVT, risk assessment and thrombolysis in acute PE, selection and reversal of anticoagulants, prevention of post-thrombotic syndrome and effective care transitions.
1Lenchus, J. D., Biehl, M., Cabrera, J., Moraes, A. G. D., & Dezfulian, C. (2017). In-Hospital Management and Follow-Up Treatment of Venous Thromboembolism: Focus on New and Emerging Treatments. Journal of Intensive Care Medicine, 32(5), 299-311.